A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II–III malignant pleural mesothelioma

Lucchi, Marco; Chella, Antonio; Melfi, Franca; Dini, Paolo; Ambrogi, Marcello; Fino, Leonardo; Fontanini, Gabriella; Mussi, Alfredo
March 2007
European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p529
Academic Journal
Abstract: Objective: From therapeutic nihilism to extremely aggressive management, there is a wide range of possibilities in the treatment of malignant pleural mesothelioma (MPM). Unfortunately, there is little evidence as regards the best treatment to offer to the MPM patients. In 1999, we started a phase II study based on the multimodality treatment of stage II–III MPM, the results of which have been analysed and reported. Methods: From 1999 to 2004, 49 patients with IMIG stage II–III MPM underwent a multimodality treatment including: intrapleural pre-operative interleukin 2 (IL-2, 18×106 UI/day per 3 days), pleurectomy/decortication, intrapleural post-operative epidoxorubicin (25mg/m2 per 3 days), IL-2 (18×106 UI/day per 3 days), adjuvant radiotherapy (30Gy), systemic chemotherapy (cisplatin 80mg/m2 day 1, gemcitabine 1250mg/m2 day 1 and 8 up to 6 courses) and long-term sub-cutaneous IL-2 (3×106 UI/day 3 days per week). Results: There were 41 males and 8 females with a median age of 61 years (range 41–77). All the patients had a diagnosis of MPM by thoracoscopy before inclusion. We did not experience any post-operative mortality. The histology was: 39 epitheliomorf, 6 bifasic and 4 sarcomatous. According to the IMIG the post-operative staging was III in 40 cases and II in 9 cases. With a median follow-up of 59 months (range 14–81) 13 patients are still alive and the median actuarial survival is 26 months (31 and 21 months for stage II and III, respectively). Only the Performance Status at the diagnosis affected survival significantly. Conclusions: The multimodality treatment we adopted for stage II–III MPM was feasible, well tolerated by most of the patients and produced a favourable outcome. New targeted therapies are awaited for further improvements in the treatment of this disease.


Related Articles

  • Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial. El-Sayed, Mohamed I.; Maximous, Doaa W.; Aboziada, Mohamed A.; Abdel-Wanis, Mostafa E.; Mikhail, Nabiel N. H. // Annals of Surgical Innovation & Research;2010, Vol. 4, p5 

    Background: Neoadjuvant chemotherapy is the standard care for locally advanced breast cancer. Our study aimed at evaluating the feasibility of breast conversation surgery (BCS) after neoadjuvant chemotherapy. Patients and methods: Forty five patients had stage IIB (except those with T2N1...

  • Delayed diagnosis of oral squamous cell carcinoma: a case series.  // Journal of Medical Case Reports;2011, Vol. 5 Issue 1, p1 

    The article presents three case studies of oral squamous cell carcinomas (OSCC) which includes 52-year-old Turkish man, 61 year old Turkish man and a 60 year old Turkish women. It states that all three were referred to Ankara University Faculty of Dentistry after suffered from pain and swelling...

  • Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity. Nour, Alaa Ahmad; Alaradi, Aziz; Mohamed, Adel; Altuwaijri, Saleh; Rudat, Volker // Radiation Oncology;2013, Vol. 8 Issue 1, p1 

    Background: The goal of this study was to assess a possible dosimetric advantage of intensity modulated radiotherapy (IMRT) of upper abdominal malignancies compared to three-dimensional conformal radiotherapy (3DCRT), and to assess the impact of IMRT on acute toxicity. Methods: Thirty-one...

  • Testis cancer. Khan, Omar; Protheroe, Andrew // Postgraduate Medical Journal;Oct2007, Vol. 83 Issue 984, p624 

    Testis cancer is an increasing problem, especially in northern European male populations. However, survival has improved dramatically over one generation. Environmental factors may have a role in the aetiology with high oestrogen concentrations implicated. Testis cancer is subdivided between...

  • Breast cancer. Part 2: present and future treatment modalities. Harmer, Victoria // British Journal of Nursing;9/11/2008, Vol. 17 Issue 16, p1028 

    This is the second article in a series of three on breast cancer. Part 1 discussed breast anatomy, the principles behind breast awareness and breast health, detailing common benign breast diseases, types of breast cancer and staging. In this article, treatment for breast cancer is discussed. The...

  • Post-treatment parenthood in Hodgkin's lymphoma survivors. Kiserud, C. E.; Fosså, A.; Holte, H.; Fosså, S. D. // British Journal of Cancer;5/7/2007, Vol. 96 Issue 9, p1442 

    Attempted and achieved post-treatment parenthood, with or without use of assisted reproduction techniques (ARTs), was assessed in Hodgkin's lymphoma survivors treated from 1971–1998, aged below 50 (females) or 65 (males) at diagnosis, aged 18 to 75 at survey. Four treatment groups were...

  • Management of colorectal cancer: 20 years’ experience. Miliaras, S.; Trygonis, K.; Papadoniou, A.; Toufektsis, T.; Tsavdarides, P.; Mikrou, I.; Kiskinis, D. // Techniques in Coloproctology;Nov2004 Supplement 1, Vol. 8, ps68 

    Colorectal cancer is the second most common cause of cancer death in westernised countries. Its treatment is the subject of active, ongoing investigation within all treatment modalities, including surgery, chemotherapy and radiotherapy. We reviewed the charts of all patients treated in this...

  • A case of germinoma in the septum pellucidum manifesting as amnesia and hemiparesis. Sato, K.; Nagayama, T.; Fujimura, M.; Okamoto, K.; Kamiya, M.; Nakazato, Y. // Acta Neurochirurgica;Oct2003, Vol. 145 Issue 10, p923 

    Summary ¶Background. We report a rare case of germinoma mainly located in the septum pellucidum. Case description. A 19-year-old man presented with germinoma located in the septum pellucidum manifesting as amnesia and right hemiparesis. Magnetic resonance imaging demonstrated a...

  • Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensitymodulated radiotherapy. Mei Feng; Weidong Wang; Zixuan Fan; Binyu Fu; Jie Li; Shichuan Zhang; Jinyi Lang // Radiation Oncology;2013, Vol. 8 Issue 1, p1 

    Background: To retrospectively analyze whether primary tumor volume and primary nodal volume could be considered independent prognostic factors for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Methods: Three hundred sixty-three consecutive nasopharyngeal carcinoma...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics